These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens. Ting CC, Law LW. J Immunol; 1977 Apr 15; 118(4):1259-64. PubMed ID: 191534 [Abstract] [Full Text] [Related]
11. Selection and rejection of retrovirus-expressing tumor cells from a heterogeneous murine leukemia virus-infected cell population. Zbar B, Terata N, Nagai A, Tanio Y, Hovis J. Cancer Res; 1984 Oct 15; 44(10):4622-9. PubMed ID: 6088041 [Abstract] [Full Text] [Related]
17. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity. Kasai M, Yamaguchi H, Hosokawa M, Mizushima Y, Kobayashi H. J Natl Cancer Inst; 1981 Aug 15; 67(2):417-22. PubMed ID: 6267345 [Abstract] [Full Text] [Related]
18. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response. Gordon WC, Prager MD. Cancer Res; 1977 Feb 15; 37(2):507-13. PubMed ID: 832275 [Abstract] [Full Text] [Related]
19. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens. Chism SE, Wallis S, Burton RC, Warner NL. J Immunol; 1976 Nov 15; 117(5 Pt.2):1870-7. PubMed ID: 993583 [Abstract] [Full Text] [Related]
20. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses. Vallera DA, Mentzer SJ, Maizel SE. Cancer Res; 1982 Feb 15; 42(2):397-404. PubMed ID: 7055792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]